Friday, 23 Mar 2018

You are here

RheumNow Week in Review – 12 August 2016

Highlights from this week on include:

  1. ViDEO: Pearls on Methotrexate side effect management from Dr. Jack Cush at 2016 RNS meeting. Thanks to Healio!
  2. Great review of Raynauds Phenomenon in NEJM by Dr. Fred Wigley
  3. 10 Essential Facts about Seronegative #RA. It's the symptoms, not the labs that count most. 20% of RA is seronegative
  4. Walgreens establishes disposal “kiosk” for patients needing to discard old/dangerous/narcotic meds. .
  5. In Japan, persistence on biologics highest in biologic-naïve (>95%) and older Pts & lowest w/ more comorbidities.
  6. Should low-dose prednisone be used in Osteoarthritis? Conflicting data in RCTs
  7. There are 3 kinds "hip pain" - 1 Buttock pain (70% from LS spine); 2. Side/trochanteric pain (20% from FM, Bursitis); 3. Anterior/groin (true hip Jt) (<10%)
  8. A single center 9 yr follow up study of 97 myositis saw 25% died, most from Infx(29%). Death increased w/ lung Dz (HR 1.8), infection (HR 4.2)
  9. There is No Added Lymphoma Risk with TNF Inhibitor Use
  10. Etanercept May Lower Alzheimers Risk in Rheumatoid Arthritis
  11. Cryptochromes Regulate Circadian Inflammation in RA
  12. 2016 EULAR Update to Gout Guidelines
  13. My Nurse Practitioner
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

The RheumNow Week in Review - 23 March 2018

Dr. Jack Cush reviews the highlights from the news, journals and major meetings. New announcements and approval from the FDA; novel associations between ANCA vasculitis and thyroid disease; flare rates after arthroplasty; and pregnancy outcomes for men and women.

MMWR: Arthritis Prevalence Increases and Varies Widely

MMWR reports that In 2015, the number of adults with arthritis continued to increase; with marked geographic variability in arthritis estimates with gaps in arthritis management.

The CDC estimates that physician-diagnosed arthritis affects 54 million of adults in the United States with an annual cost of approximately $300 billion annually.

The RheumNow Week in Review - 16 March 2018

Dr. Jack Cush reviews the highlights from the news, journals and major meetings. Bigtime rheumatologic lessons with tales from intestinal crypts, the friendly skies & the hips of hockey players. Also the microbiome and lupus, benefits of ENT findings with GPA and rare risk of opportunistic infections with biologics.

The RheumNow Week in Review - 9 March 2018

Dr. Jack Cush reviews highlights, news and recent research published this past week on This week's report includes news on new regulatory changes, new indication for tofacitinib, the rise and deficits of opioids and the benefits of fish and bariatric surgery.

ACR Responds to Association Health Plans Proposed Rule

In comments submitted today to the US Department of Labor in response to its Association Health Plans (AHP) proposed rule, the American College of Rheumatology urged Administration officials to protect essential health benefits and other consumer protections that make it possible for individuals living with rheumatic diseases to access comprehensive and affordable healthcare.